ScopusElsevier Scopus
Status
Active
Coverage
1996–present
Source type
Journal
Open access
No
CiteScore
6.6
SJR · SCImago
0.796
Q1 SJR quartile
H-index
90
Best quartile
Q1 · 88th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Dermatology | 18 / 152 | 88th | Q1 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Dermatologic Therapy
Dermatologic Therapy is Scopus-indexed (Q1, CiteScore 6.6), WoS SCIE, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 1396-0296Verify ISSN ↗1529-8019Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Scopus · Q1WoS · SCIEOpen Access
6.6
CiteScore 2025
Q1
Best quartile
3
Indexed in
Cost to publish: Checking DOAJ for article charges…
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Dermatologic Therapy indexed in Scopus?
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q1, CiteScore 6.6.
What quartile is Dermatologic Therapy in Scopus?
Dermatologic Therapy is Q1 in Dermatology (rank 18 of 152), by CiteScore 2025.
What is the impact factor of Dermatologic Therapy?
Dermatologic Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.6, which places it in quartile Q1 at the 88th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.796, quartile Q1, with an H-index of 90.
How much does it cost to publish in Dermatologic Therapy?
The publisher lists an article processing charge of about US$2,700 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Dermatologic Therapy and what is its ISSN?
Dermatologic Therapy is published by John Wiley and Sons Inc. Its print ISSN is 1396-0296 and its online ISSN is 1529-8019.
Is Dermatologic Therapy in Web of Science?
Yes — indexed in the Science Citation Index Expanded.
Is Dermatologic Therapy open access?
Yes — it is an open-access journal, listed in DOAJ.
How well cited is Dermatologic Therapy? — open metrics via OpenAlex
Dermatologic Therapy has an h-index of 104 and a 2-year mean of 0.6 citations per paper (OpenAlex). Its Scopus CiteScore is 6.6, quartile Q1. On 2-year citations it ranks #99 of 144 Scopus journals in Dermatology.
104
h-index
0.6
2-yr mean citations
2,276
i10-index
5,519
works indexed
86,983
total citations
Publication fee · open access list price, US$
US$2,700
2-yr mean citations, among Scopus journals in the same subject
#99 of 144 Bottom 32% Dermatology
Dermatologic Therapy published 122 papers in 2025; its busiest recent year was 2020 with 1,535. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Dermatologic Therapy? — latest 98 articles, 2026
In its latest 98 research articles (2026), authors are most often from China (52.8%), Italy (6%) and United States (5.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Dermatologic Therapy? — indicators, not proof of misconduct
Scopus status: Active. 5 retracted papers are recorded (0.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 5 · 0.9 per 1,000 papers
- Problematic Paper Screener flags None flagged
- Author concentration52.8% of recent authorship from China
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journals Journal Indexed in
Diabetes, Obesity and Metabolism Scopus Q1 WoS SCIE Diagnostic Cytopathology Scopus Q3 WoS SCIE Dialog Scopus Q3 WoS AHCI Digestive Endoscopy Scopus Q1 WoS SCIE Domes : Digest of Middle East Studies Scopus Q1 WoS ESCI Droplet Scopus Q1 WoS ESCI DOAJ Earthquake Engineering and Resilience Scopus Q2 WoS ESCI Earthquake Spectra Scopus Q1 WoS SCIE
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.